Stock Code: 002082
Stock Abbreviation: ST Wanbang
Announcement No.: 2026-059
Wanbangde Pharmaceutical Holdings Group Co., Ltd.
Announcement on Progress and Risk Alert Regarding Company Stock Trading Subject to Other Risk Warnings
The Company and the entire Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
I. Situation Regarding the Company Being Subject to Other Risk Warnings
Beijing Dehao Certified Public Accountants (Special General Partnership) (hereinafter referred to as "Beijing Dehao"), the 2025 annual audit firm for Wanbangde Pharmaceutical Holdings Group Co., Ltd. (hereinafter referred to as the "Company"), issued a qualified opinion on the Company's internal controls for the year 2025.
According to Article 9.8.1 (IV) of the Shenzhen Stock Exchange Stock Listing Rules (hereinafter referred to as the "Listing Rules"), due to the qualified audit report on internal controls over financial reporting for the most recent fiscal year, the Company's stock trading has been subject to other risk warnings by the Shenzhen Stock Exchange.
II. Measures Taken and Progress of Related Work
The Company's Board of Directors attaches great importance to the matters involved in the non-standard audit opinion. The Company's management is actively taking action to strive to eliminate the impact of the matters leading to the other risk warnings on the Company's stock trading as soon as possible. Meanwhile, the Company is continuously optimizing its internal control construction and enhancing its corporate governance level. The main measures taken and their progress are as follows: